SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-20-032004
Filing Date
2020-03-11
Accepted
2020-03-11 17:14:22
Documents
51
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tm205356d1_10k.htm 10-K 873438
2 EXHIBIT 4.3 tm205356d1_ex4-3.htm EX-4.3 54505
3 EXHIBIT 23.1 tm205356d1_ex23-1.htm EX-23.1 2560
4 EXHIBIT 31.1 tm205356d1_ex31-1.htm EX-31.1 8814
5 EXHIBIT 31.2 tm205356d1_ex31-2.htm EX-31.2 8545
6 EXHIBIT 32.1 tm205356d1_ex32-1.htm EX-32.1 4501
7 EXHIBIT 32.2 tm205356d1_ex32-2.htm EX-32.2 4362
  Complete submission text file 0001104659-20-032004.txt   4040660

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT ckpt-20191231.xml EX-101.INS 807340
9 XBRL TAXONOMY EXTENSION SCHEMA ckpt-20191231.xsd EX-101.SCH 38434
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ckpt-20191231_cal.xml EX-101.CAL 32495
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ckpt-20191231_def.xml EX-101.DEF 145841
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE ckpt-20191231_lab.xml EX-101.LAB 267557
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ckpt-20191231_pre.xml EX-101.PRE 244556
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38128 | Film No.: 20706164
SIC: 2834 Pharmaceutical Preparations